Petrolini-Mateus Adriano, Araujo Gustavo Henrique Guimarães, Schafauser-Segundo Nathany Souza, Leonardi Naiara Tais, Castello-Simões Viviane, Hurst John R, Mendes Renata Gonçalves
Department of Physical Therapy, Federal University of São Carlos, São Paulo, Brazil.
UCL Respiratory, University College London, London, UK.
BMC Pulm Med. 2025 May 10;25(1):232. doi: 10.1186/s12890-025-03697-8.
Chronic respiratory diseases (CRD) often coexist with other non-communicable diseases (NCD) and are responsible for nearly three-quarters of all deaths in low- and middle-income countries (LMIC). People living with NCD are considered at higher risk of having CRD, but the prevalence of CRD in those with other NCD in LMIC is not well described. This study aimed to identify the prevalence of CRD and/or abnormal spirometry identified through case-finding tools in adults living with NCD in LMIC.
This systematic review followed the PRISMA guidelines and included Lilacs, PubMed, Scielo, Embase and Web of Science databases. Two reviewers independently examined the titles and abstracts of studies identified from the search to determine eligibility for inclusion. Searching was carried out until May 16, 2024, and was updated in February 2025. Cross-sectional studies that used case finding tools to identify CRD in adults living with other NCD in LMIC were eligible. The studies were exported to Rayyan software, and duplicates were manually removed. Data were extracted including study characteristics, and quality was assessed using the modified Newcastle-Ottawa Scale risk of bias tool. A descriptive analysis of the prevalence of respiratory diseases and spirometric abnormalities was reported considering 95% confidence intervals.
A total of 8,939 citations were screened based on titles and abstracts. Thirteen full-text articles were assessed for eligibility. Five studies were excluded for not providing sufficient data, two for inadequate outcome ascertainment, two for being conducted in developed countries, and one for only including patients with a previous COPD diagnosis. Three cross-sectional studies met the inclusion criteria, one conducted in India, and two in Brazil. Considering studies with a low risk of bias, the prevalence of CRD was between 1% and 5.2% in patients with hypertension. The prevalence of abnormal spirometry was between 11% and 17% in patients with coronary artery disease.
The prevalence of CRD identified through case-finding tools in adults with NCD in LMIC varies according to the NCD in which it was investigated. These findings highlight the opportunity to case-find CRD by assessing people accessing care for other NCD.
PROSPERO 2024 CRD42024534734.
慢性呼吸道疾病(CRD)常与其他非传染性疾病(NCD)共存,在低收入和中等收入国家(LMIC)中,CRD导致了近四分之三的死亡。患有非传染性疾病的人群被认为患CRD的风险更高,但低收入和中等收入国家中患有其他非传染性疾病的人群中CRD的患病率尚无充分描述。本研究旨在确定通过病例发现工具在低收入和中等收入国家患有非传染性疾病的成年人中CRD和/或异常肺功能测定的患病率。
本系统评价遵循PRISMA指南,纳入了Lilacs、PubMed、Scielo、Embase和Web of Science数据库。两名评审员独立审查检索到的研究的标题和摘要,以确定是否符合纳入标准。检索持续至2024年5月16日,并于2025年2月更新。使用病例发现工具在低收入和中等收入国家患有其他非传染性疾病的成年人中识别CRD的横断面研究符合要求。研究被导出到Rayyan软件中,并手动删除重复项。提取的数据包括研究特征,并使用改良的纽卡斯尔-渥太华量表偏倚风险工具评估质量。报告了考虑95%置信区间的呼吸道疾病和肺功能异常患病率的描述性分析。
基于标题和摘要共筛选了8939条引文。评估了13篇全文文章的 eligibility。5项研究因未提供足够数据被排除,2项因结局确定不充分被排除,2项因在发达国家进行被排除,1项因仅纳入既往诊断为慢性阻塞性肺疾病的患者被排除。3项横断面研究符合纳入标准,1项在印度进行,2项在巴西进行。考虑到偏倚风险较低的研究,高血压患者中CRD的患病率在1%至5.2%之间。冠心病患者中异常肺功能测定的患病率在11%至17%之间。
通过病例发现工具在低收入和中等收入国家患有非传染性疾病的成年人中识别出的CRD患病率因所调查的非传染性疾病而异。这些发现突出了通过评估因其他非传染性疾病就诊的人群来发现CRD的机会。
PROSPERO 2024 CRD42024534734 。